Literature DB >> 17015523

Does cause of deafness influence outcome after cochlear implantation in children?

Thomas P Nikolopoulos1, Sue M Archbold, Gerard M O'Donoghue.   

Abstract

OBJECTIVES: The objective of this study was to evaluate long-term speech perception abilities of comparable groups of postmeningitic and congenitally deaf children after cochlear implantation.
METHODS: This prospective longitudinal study comprised 46 postmeningitic deaf children and 83 congenitally deaf children with age at implantation of < or = 5.6 years. Both groups were comparable with respect to educational setting and mode of communication and included children with additional disabilities.
RESULTS: Both postmeningitic and congenitally deaf children showed significant progress after implantation. Most (73% and 77%, respectively) could understand conversation without lip-reading or use the telephone with a known speaker 5 years after implantation, whereas none could do so before implantation. At the same interval, the postmeningitic and congenitally deaf children scored a mean open-set speech perception score of 47 (range: 0-91) and 46 (range: 0-107) words per minute, respectively, on connected discourse tracking. The respective mean scores at the 3-year interval were 22 and 29 correct words per minute, respectively. None of these children could score a single correct word per minute before implantation. The progress in both groups was statistically significant. When the 2 groups were compared, there was no statistically significant difference.
CONCLUSION: Postmeningitic and congenitally deaf children showed significant improvement in their auditory receptive abilities at the 3- and 5-year intervals after cochlear implantation. There was no statistically significant difference between the outcomes of the 2 groups, suggesting that, provided that children receive an implant early, cause of deafness has little influence on outcome. Although the prevalence of other disabilities was similar in both groups, for individual children, their presence may have profound impact. The study supports the concept of implantation early in life, irrespective of the cause of deafness.

Entities:  

Mesh:

Year:  2006        PMID: 17015523     DOI: 10.1542/peds.2006-0502

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Outcomes of Cochlear Implantation in Patients with Post-Meningitis Deafness: A Systematic Review and Narrative Synthesis.

Authors:  Kaajal Singhal; Juhi Singhal; Jameel Muzaffar; Peter Monksfield; Manohar Bance
Journal:  J Int Adv Otol       Date:  2020-12       Impact factor: 1.017

2.  New cochlear implant technologies improve performance in post-meningitic deaf patients.

Authors:  Isabelle Mosnier; Andrea Felice; Gonzalo Esquia; Stéphanie Borel; Didier Bouccara; Emmanuèle Ambert-Dahan; Martine Smadja; Evelyne Ferrary; Olivier Sterkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-12       Impact factor: 2.503

3.  Expected test scores for preschoolers with a cochlear implant who use spoken language.

Authors:  Johanna G Nicholas; Ann E Geers
Journal:  Am J Speech Lang Pathol       Date:  2008-05       Impact factor: 2.408

4.  A Comparison of Surgical Auditory Nerve Response and Speech Outcomes in Patients with Post-meningitic Deafness and Without Cochlear Osteogenesis Who Underwent Cochlear Implantation.

Authors:  Mohammed Alshaikh; Asmaa Alahmadi; Mohammed Albedry; Abdulmajeed Alharbi; Saad Alenzi; Rawan Almahyawi; NoorJehan Mansouri; Mohammad Albaqeyah; Abdullah Alamri; Amani A Alharbi; Ahmad Aldajani
Journal:  Cureus       Date:  2019-09-13

5.  Long-Term Outcome of Cochlear Implantation in Post-meningitic Deafnes.

Authors:  Ozan Muzaffer Altuntaş; Burcu Özkan; Demir Bajin; Gonca Sennaroğlu; Levent Sennaroğlu
Journal:  J Int Adv Otol       Date:  2021-11       Impact factor: 1.017

6.  Bilateral Cochlear Implantation in Meningitis, Is it Mandatory? A Case Report.

Authors:  Mohammad Ajalloueyan; Susan Amirsalari; Shahla Afsharpeyman
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.